Chungnam Province has succeeded in attracting an investment worth 300 billion KRW from the global biopharmaceutical company Celltrion. This is the first time a major biopharmaceutical company has invested in Chungnam.


On the 30th, Chungnam Province announced that Governor Kim Tae-heum, Celltrion Chairman Seo Jung-jin, and Yesan County Governor Choi Jae-gu met at the Chungnam Provincial Office to sign an investment agreement.


According to the agreement, Celltrion plans to establish production facilities on a 99,291㎡ site within the Yesan 2nd General Industrial Complex by December 2028.


Celltrion is a global company that recorded sales of 2.3 trillion KRW last year and is reportedly planning to add production facilities to meet the increasing supply demand for biopharmaceuticals.


Chungnam Province and Yesan County expect economic effects such as a 699 billion KRW change in production output, a 300.4 billion KRW change in added value, and approximately 1,500 new jobs in Yesan County if Celltrion's investment proceeds as planned.


The one-time effects from the factory construction are analyzed to include 434.9 billion KRW in induced production, 160.7 billion KRW in induced added value, and 4,405 induced jobs.



Governor Kim Tae-heum of Chungnam Province said, “Celltrion is a leading domestic biopharmaceutical company,” and added, “I hope Celltrion will grow into a global company that treats human diseases through new drug development in Chungnam.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing